← Andrew Hillman

Medical and Research Disclaimer

Last updated June 2026

This page is for general informational purposes only. It is not legal advice and not medical advice. Consult qualified legal counsel and a licensed physician before acting on anything described here. Nothing on this site is an offer to treat. Eligibility and informed consent are determined by licensed physicians under applicable law.

This site is published for education and general information. Read this disclaimer before relying on anything here.

No medical advice

Content on this site is educational and general. It does not diagnose, treat, or prescribe, and it does not create a doctor and patient relationship. Do not delay or disregard professional medical care based on anything you read here.

Investigational status

Any cell, tissue, exosome, or other regenerative therapy referenced is investigational. It is not approved or licensed by the United States Food and Drug Administration. There are no FDA approved exosome products.

No guarantee of outcome

No result is promised or implied. Outcomes vary by person. References to research, including early phase or preclinical work, do not establish safety or effectiveness.

Physician and consent

Whether any therapy is appropriate, available, or lawful for a given person is determined solely by a licensed physician under applicable law, with informed consent. Nothing here is an offer to treat or a solicitation to receive treatment.

No attorney-client relationship

Andrew Hillman is a corporate strategist, biotech advisor, and expert witness. He is not a licensed attorney, and nothing on this website is legal advice. All strategic advisory and expert witness services are performed under the direction of retaining legal counsel or authorized corporate entities. No attorney-client relationship is created through this website, its forms, or email. A formal engagement exists only after a licensed lawyer or law firm has explicitly retained Andrew Hillman through fully executed, signed written documents. Unsolicited materials sent through this site are not confidential and are not subject to privilege.

HIPAA and protected health information

This website is for corporate, B2B, and educational research purposes only. It is not a clinical portal, patient care platform, or diagnostic tool. Do not upload or transmit any Protected Health Information (PHI) or individually identifiable health data through this site's public forms or email. Any unsolicited health or patient data received will be purged. Patient case files or clinical data for expert-witness or scientific evaluation must be handled only through secure, encrypted channels governed by a Business Associate Agreement (BAA) or court-issued protective order.

Research references

Citations and links are provided for education. They are not endorsements and may include preprints or other works that have not completed peer review.

Further reading

See the FDA public safety alert on unapproved stem cell and exosome products and 21 CFR Part 1271 for the regulatory framework. Links are available through the FDA website at fda.gov.